المؤلفون: Turunen, Antti, Partanen, Anu, Valtola, Jaakko, Ropponen, Antti, Siitonen, Timo, Kuittinen, Outi, Kuitunen, Hanne, Putkonen, Mervi, Sankelo, Marja, Keskinen, Leena, Savolainen, Eeva-Riitta, Pyörälä, Marja, Kuittinen, Taru, Silvennoinen, Raija, Penttilä, Karri, Sikiö, Anu, Vasala, Kaija, Mäntymaa, Pentti, Pelkonen, Jukka, Varmavuo, Ville, Jantunen, Esa

المساهمون: Department of Oncology, HUS Comprehensive Cancer Center, HYKS erva, Hematologian yksikkö, Kymsote – Social and Health Services in Kymenlaakso

مصطلحات موضوعية: Surgery, anesthesiology, intensive care, radiology, STEM-CELL TRANSPLANTATION, PLUS G-CSF, HEMATOPOIETIC STEM, POOR MOBILIZATION, RISK-FACTORS, CYCLOPHOSPHAMIDE, MORTALITY, IMPACT, VOLUME, PLERIXAFOR, Cancers

وصف الملف: application/pdf

Relation: Turunen , A , Partanen , A , Valtola , J , Ropponen , A , Siitonen , T , Kuittinen , O , Kuitunen , H , Putkonen , M , Sankelo , M , Keskinen , L , Savolainen , E-R , Pyörälä , M , Kuittinen , T , Silvennoinen , R , Penttilä , K , Sikiö , A , Vasala , K , Mäntymaa , P , Pelkonen , J , Varmavuo , V & Jantunen , E 2020 , ' CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkinʼs lymphoma patients: results of the prospective multicenter Goa study ' , Transfusion , vol. 60 , no. 7 , pp. 1519-1528 . https://doi.org/10.1111/trf.15820; RIS: urn:25FE059F9304B389110D8282DAB15616; http://hdl.handle.net/10138/318029; e58d0a80-ee65-493d-b50f-d994cf8f09e7; 000528186700001

الاتاحة: http://hdl.handle.net/10138/318029

المؤلفون: Duarte, D, Amarteifio, S, Ang, H, Kong, IY, Ruivo, N, Pruessner, G, Hawkins, ED, Lo Celso, C

المساهمون: Human Frontier Science Program, Bloodwise, Commission of the European Communities, European Hematology Association, Biotechnology and Biological Sciences Research Council (BBSRC), Blood Cancer UK, Cancer Research UK

المصدر: 235 ; 229

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Cell Biology, Immunology, Acute myeloid leukemia cells, chemokines, intravital imaging, lymphoblastic leukemia, PLUS G-CSF, CXCR4, CHEMOTHERAPY, CHEMOSENSITIZATION, MOBILIZATION, INHIBITION, PROGENITOR, Animals, Antineoplastic Agents, Bone Marrow, Cell Line, Tumor, Cell Movement, Chemokine CXCL12, Drug Resistance, Neoplasm, Heterocyclic Compounds, Intravital Microscopy, Leukemia, Myeloid, Acute, Mice

جغرافية الموضوع: United States

Relation: Immunology and Cell Biology; http://hdl.handle.net/10044/1/66316; rgp0051/2011; 12033; 337066; n/a; BB/L023776/1; 15031; BB/I004033/1; 11831

الاتاحة: http://hdl.handle.net/10044/1/66316
https://doi.org/10.1111/imcb.12216

المؤلفون: Varmavuo, Ville, Silvennoinen, Raija, Anttila, Pekka, Saily, Marjaana, Sankelo, Marja, Putkonen, Mervi, Ahonen, Jouni, Mahlamaki, Eija, Mantymaa, Pentti, Savolainen, Eeva-Riitta, Remes, Kari, Jantunen, Esa

المساهمون: Department of Oncology, Clinicum, Hematologian yksikkö, Department of Medicine

مصطلحات موضوعية: Stem cell mobilization, Autologous stem cell transplantation, Multiple myeloma, Cost analysis, Cyclophosphamide, Plerixafor, COLONY-STIMULATING FACTOR, PLUS G-CSF, LOW-DOSE CYCLOPHOSPHAMIDE, TRANSPLANTATION, CHEMOTHERAPY, STRATEGIES, GUIDELINES, EFFICACY, OUTCOMES, Cancers

وصف الملف: application/pdf

Relation: VV has received consultancy fees from Roche, Celgene, Amgen, and Sanofi. RS has received a research grant from Celgene and Janssen, honoraria from Celgene, Janssen, and Sanofi. KR has participated in the Medical Advisory Board organized by Amgen and Takeda and has received consultancy fees from Amgen, Celgene, Roche, and Takeda. EJ has received honoraria from Genzyme, Amgen, and Sanofi and has participated in an EU Leadership meeting organized by Genzyme as well as a Medical Advisory Board meeting organized by Amgen and Takeda. The other authors have no conflicts of interest to disclose.; Varmavuo , V , Silvennoinen , R , Anttila , P , Saily , M , Sankelo , M , Putkonen , M , Ahonen , J , Mahlamaki , E , Mantymaa , P , Savolainen , E-R , Remes , K & Jantunen , E 2016 , ' Cost analysis of a randomized stem cell mobilization study in multiple myeloma ' , Annals of Hematology , vol. 95 , no. 10 , pp. 1653-1659 . https://doi.org/10.1007/s00277-016-2772-1; http://hdl.handle.net/10138/229285; 53edf8bd-5d2d-4026-8559-eb8d4a6f89fd; 84982262060; 000387352800010

الاتاحة: http://hdl.handle.net/10138/229285

المؤلفون: Marja Pyörälä, Esa Jantunen, Kaija Vasala, Hanne Kuitunen, Ville Varmavuo, Jukka Pelkonen, Pentti Mäntymaa, Outi Kuittinen, Antti Turunen, Antti Ropponen, Mervi Putkonen, Anu Partanen, Leena Keskinen, Taru Kuittinen, Eeva-Riitta Savolainen, Jaakko Valtola, Timo Siitonen, Marja Sankelo, Raija Silvennoinen, Karri Penttilä, Anu Sikiö

المساهمون: Department of Oncology, HUS Comprehensive Cancer Center, HYKS erva, Hematologian yksikkö, Kymsote – Social and Health Services in Kymenlaakso

المصدر: Transfusion. 60:1519-1528

مصطلحات موضوعية: Male, Benzylamines, IMPACT, Antigens, CD34, 030204 cardiovascular system & hematology, Cyclams, Gastroenterology, PLUS G-CSF, 0302 clinical medicine, Autologous stem-cell transplantation, immune system diseases, hemic and lymphatic diseases, CYCLOPHOSPHAMIDE, Immunology and Allergy, Prospective Studies, Autografts, Prospective cohort study, Multiple myeloma, Lymphoma, Non-Hodgkin, Hematology, Middle Aged, Hematopoietic Stem Cell Mobilization, Survival Rate, Female, Multiple Myeloma, medicine.drug, Adult, medicine.medical_specialty, Cyclophosphamide, 3122 Cancers, Immunology, Disease-Free Survival, PLERIXAFOR, 03 medical and health sciences, Internal medicine, medicine, Humans, POOR MOBILIZATION, Survival rate, Aged, Peripheral Blood Stem Cell Transplantation, business.industry, MORTALITY, Plerixafor, STEM-CELL TRANSPLANTATION, 3126 Surgery, anesthesiology, intensive care, radiology, medicine.disease, Lymphoma, HEMATOPOIETIC STEM, VOLUME, Peripheral Blood Stem Cells, RISK-FACTORS, business, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da4122c64b23b6ebdd5ad3ae7826e6f4
https://doi.org/10.1111/trf.15820

المؤلفون: Selleslag, D, Lambert, C, Zachee, P, Huyngh, P, Van de Velde, A, Noens, Lucien, Baily, L, André, M, Willems, E, Dierickx, D

المصدر: ACTA CLINICA BELGICA ; ISSN: 1784-3286

مصطلحات موضوعية: Medicine and Health Sciences, Non-Hodgkin's lymphoma, Multiple myeloma, Plerixafor, Poor mobilizers, TRANSPLANTATION, PROGENITOR-CELL, PLUS G-CSF, HIGH-DOSE CYCLOPHOSPHAMIDE, COLONY-STIMULATING FACTOR, MULTIPLE-MYELOMA PATIENTS, NON-HODGKINS-LYMPHOMA, LENALIDOMIDE, ALGORITHM, Hodgkin's lymphoma, MOBILIZING REGIMEN

وصف الملف: application/pdf

Relation: https://biblio.ugent.be/publication/5970858; http://hdl.handle.net/1854/LU-5970858; http://dx.doi.org/10.1179/2295333714Y.0000000077; https://biblio.ugent.be/publication/5970858/file/5970870

الاتاحة: https://biblio.ugent.be/publication/5970858
http://hdl.handle.net/1854/LU-5970858
https://doi.org/10.1179/2295333714Y.0000000077
https://biblio.ugent.be/publication/5970858/file/5970870

المؤلفون: Balçık, Özlem Şahin, Dağdaş, Simten, Güler, Sema Keser, Özet, Gülsüm, Oymak, Ahmet, Çelik, Zafer, Aylı, Meltem

مصطلحات موضوعية: Transplantation, Autologous, Tissue and organ harvesting, Colony-stimulating factor, Blood progenitor cells, Factors affecting mobilization, High-Dose chemotherapy, Plus G-Csf, Multiple-myeloma, Breast-cancer, Lymphoma patients, Growth-factor, Normal donors

وصف الملف: application/pdf

Relation: Turkiye Klinikleri Tip Bilimleri Dergisi; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/20.500.14065/2742; 28; 640; 647; WOS:000259856300009; 2-s2.0-54449083506

الاتاحة: https://hdl.handle.net/20.500.14065/2742

المؤلفون: P Huyngh, A. Van de Velde, D Selleslag, Lucien Noens, Evelyne Willems, D Dierickx, M. André, Pierre Zachee, Catherine Lambert, L Baily

المصدر: Acta clinica Belgica
ACTA CLINICA BELGICA

مصطلحات موضوعية: Male, Oncology, Benzylamines, Lymphoma, Poor mobilizers, Cyclams, CXCR4, PLUS G-CSF, HIGH-DOSE CYCLOPHOSPHAMIDE, Belgium, Heterocyclic Compounds, Multiple myeloma, hemic and lymphatic diseases, Medicine and Health Sciences, Prospective Studies, Practice Patterns, Physicians', LENALIDOMIDE, Hodgkin's lymphoma, MOBILIZING REGIMEN, Non-Hodgkin's lymphoma, General Medicine, Middle Aged, COLONY-STIMULATING FACTOR, Hematopoietic Stem Cell Mobilization, Female, Multiple Myeloma, medicine.drug, Adult, medicine.medical_specialty, PROGENITOR-CELL, Transplantation, Autologous, Internal medicine, medicine, Humans, NON-HODGKINS-LYMPHOMA, ALGORITHM, Aged, Lenalidomide, MULTIPLE-MYELOMA PATIENTS, TRANSPLANTATION, business.industry, Plerixafor, medicine.disease, Surgery, Transplantation, Clinical trial, Human medicine, business

وصف الملف: pdf; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dae9e388066c3ae28ef277f3050802be
https://hdl.handle.net/10067/1254200151162165141